Literature DB >> 171322

Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

S Stagno, D W Reynolds, A Tsiantos, D A Fuccillo, W Long, C A Alford.   

Abstract

Infants with congenitally (38) and natally (17) acquired cytomegalovirus infection were prospectively studied by means of virologic and multiple serologic assays. These infections were characterized by chronic viral excretion (measured in years). The quantity of virus excreted in the urine during early infancy was significantly greater in infants who acquired infection in utero, particularly amon those born with overt disease; thereafter, all three groups (congenital symptomatic, congenital asymptomatic, and natal) excreted similar amounts of virus. The patterns of antibody responses, particularly the fluorescent antibody response to the early antigen and the complement-fixing antibody response, further indicated that congenitally infected infants (especially symptomatic ones) bear a greater antigenic burden than do natally infected infants. From a diagnostic standpoint, the test for fluorescent antibody to the late antigen was the most sensitive assay, whereas the test for complement-fixing antibody proved to be the least useful, The indirect hemagglutination assay, although performed only in infants with natal infection, was only slightly less sensitive than the fluorescent antibody procedure; by the former technique, diagnostic rises were detected in all but one infant after the onset of viruria.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171322     DOI: 10.1093/infdis/132.5.568

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

Review 1.  Is cytomegalovirus viraemia a useful tool in managing CMV disease?

Authors:  J R Deayton
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

2.  [Cytomegaloviruses in the amniotic fluid during asymptomatic infection in the mother with transmission to the fetus].

Authors:  R Skvorc-Ranko; J N Gagnon; F Teasdale; M Fauvel; A Chagnon
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

3.  Seroepidemiology of cytomegalovirus infections during the first years of life in urban communities.

Authors:  N Cabau; M D Labadie; C Vesin; J Feingold; A Boué
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

Review 4.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

5.  A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

6.  Use of isolated nuclei in the indirect fluorescent-antibody test for human cytomegalovirus infection: comparison with microneutralization, anticomplement, and conventional indirect fluorescent-antibody assays.

Authors:  S Stagno; D W Reynolds; R J Smith
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

7.  Evaluation of anti-complement immunofluorescence test in cytomegalovirus infection.

Authors:  N Rao; D T Waruszewski; J A Armstrong; R W Atchison; M Ho
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

8.  [Experiments with simultaneous immunization against cytomegalovirus infection and rubella].

Authors:  M Just; A Bürgin-Wolff; R Hernandez
Journal:  Soz Praventivmed       Date:  1976 Sep-Oct

9.  Concomitant cytomegalovirus infection and congenital toxoplasmosis in a newborn.

Authors:  F de Zegher; J F Sluiters; P M Stuurman; E van der Voort; A P Bos; H J Neijens
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

10.  Nonradioactive PCR-enzyme-linked immunosorbent assay method for detection of human cytomegalovirus DNA.

Authors:  R D Allen; P E Pellett; J A Stewart; M Koopmans
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.